Rchr
J-GLOBAL ID：201501058937291560
Update date: Dec. 02, 2024
Kanemitsu Yoshitomi
Kanemitsu Yoshitomi | Kanemitsu Yoshitomi
Affiliation and department：
Job title：
Associate professor
Homepage URL (1)：
https://omics.med.niigata-u.ac.jp/member.html
Research field (2)：
Pharmaceuticals - analytical and physicochemistry
, Clinical pharmacy
Research theme for competitive and other funds (3)：
- 2022 - 2025 トランスオミクス解析によるがん細胞の放射線耐性応答ネットワーク解明
- 2019 - 2022 Development of new therapeutic strategies to overcome cancer radioresistance; focusing on molecules that are increased in resistant cell lines
- 2016 - 2018 Elucidation of the mechanism of radioresistance in cancer cells using trans-omics approach and development of clinical biomarkers for radiotherapy.
Papers (20)：
-
Tomohiko Ishihara, Masayoshi Tada, Yoshitomi Kanemitsu, Yuji Takahashi, Kinya Ishikawa, Kensuke Ikenaka, Makito Hirano, Takanori Yokota, Eiko N. Minakawa, Katsuhisa Saito, et al. L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. eClinicalMedicine. 2024. 102952-102952
-
Yoshitomi Kanemitsu, Daiki Kobayashi, Kohta Nakatani, Yoshihiro Izumi, Takeshi Bamba, Masaki Matsumoto. Development and Application of LC-MS/MS Method for Determination of Major Metabolites Intra/Extra Cultured Cell Lines. Proteome Letters. 2024. 9. 1. 1-11
-
Takashi Toyama, Sidi Xu, Yoshitomi Kanemitsu, Takashi Hasegawa, Takuya Noguchi, Jin-Yong Lee, Atsushi Matsuzawa, Akira Naganuma, Gi-Wook Hwang. Methylmercury directly modifies the 105th cysteine residue in oncostatin M to promote binding to tumor necrosis factor receptor 3 and inhibit cell growth. Archives of toxicology. 2023
-
Hsin-Jung Ho, Koichi Kikuchi, Daiki Oikawa, Shun Watanabe, Yoshitomi Kanemitsu, Daisuke Saigusa, Ryota Kujirai, Wakako Ikeda-Ohtsubo, Mariko Ichijo, Yukako Akiyama, et al. SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure. Physiological Reports. 2021. 9. 24. e15092
-
Anna Iwahori, Masamitsu Maekawa, Yoshitomi Kanemitsu, Yotaro Matsumoto, Yoshihisa Tomioka, Aya Narita, Torayuki Okuyama, Yoshikatsu Eto, Daisuke Saigusa, Nariyasu Mano. Global metabolomics analysis of serum from patients with Niemann-Pick disease type C. Medical Mass Spectrometry. 2020. 4. 1. 1-11
ｍore...
MISC (44)：
-
金光祥臣, 松本雅記. Multi-omics analysis of radioresistant cancer cell lines. 日本薬学会年会要旨集(Web). 2024. 144th
-
豊原 敬文, 山本 多恵, 金光 祥臣, 菊地 晃一, 渡邉 駿, 鈴木 健弘, 田中 哲洋, 阿部 高明. 血液透析導入期における血中腸内細菌由来尿毒素の解析. 日本透析医学会雑誌. 2023. 56. Suppl.1. 653-653
-
金光祥臣, 小林大樹, 中谷航太, 和泉自泰, 馬場健史, 松本雅記. Development of a method for absolute quantification of the major metabolomes of cancer cells using LC-MS/MS and its application to metabolic analysis. 日本分子生物学会年会プログラム・要旨集(Web). 2023. 46th
-
熊谷知大, 小田垣水晶, 秋山泰利, 松本洋太郎, 塚本宏樹, 金光祥臣, 富岡佳久. 糖尿病性腎臓病評価法に用いる蛍光標識フェニルサルフェートの合成. 日本薬学会東北支部大会講演要旨集. 2023. 62nd
-
金光祥臣. 【How to 編】臨床研究を始める前に~規制と倫理を正しく理解する. 日本医療薬学会年会講演要旨集(Web). 2022. 32
ｍore...
Patents (1)：
Professional career (1)：
Work history (6)：
Awards (1)：
- 2016/09 - 医療薬学会 第 26 回日本医療薬学会年会 優秀演題賞
Return to Previous Page
